Dermatology
Latest News
Dupilumab outcomes stable at end of open label atopic dermatitis study
Other recent research on the biologic has shown that it improves lesional skin barrier function and rapidly reduces the abundance of ...
Latest News
Scientists discover variants, therapy for disabling pansclerotic morphea
The JAK inhibitor ruxolitinib dramatically improved wound healing and rashes in patients with the very rare disorder.
Latest News
JAK-inhibitor safety in adolescents with AD: Long-term analyses reported
For abrocitinib, "we're starting to get good numbers of [adolescents] who've had about 2 years of exposure," Dr. Lawrence Eichenfield said.
Latest News
Can online mindfulness and self-compassion training improve quality of life for patients with atopic dermatitis?
"Stress can make the skin worse, but at the same time the skin disease and symptoms cause stress," Dr. Peter A. Lio said.
News from the FDA/CDC
FDA approves Yuflyma as ninth adalimumab biosimilar
The manufacturer Celltrion is also seeking an interchangeability designation from the FDA, tentatively expected in the fourth quarter of 2024.
News from the FDA/CDC
FDA approves autoinjector pen for Humira biosimilar, Cyltezo
The drug will be commercially available on July 1, 2023.
Latest News
AD in infancy: Diagnostic advice and treatment tips
Among infants who are growing well and otherwise healthy, the infantile eczema phenotype encompasses AD, seborrheic dermatitis, contact dermatitis...
Latest News
CDC: Drug-resistant ringworm reported in New York
BY ALICIA AULT
The
Latest News
Facial, hand, and foot dermatitis: Lebrikizumab and dupilumab show efficacy in new studies
"Lebrikizumab was efficacious in clearing and improving facial and hand dermatitis, burdensome and difficult-to-treat areas, in most patients," Dr...
Conference Coverage
Can this tool forecast peanut allergies?
The predictive scorecard captures 14 images from one infant of mixed race, two White infants, two Black infants, and two Hispanic infants.
Latest News
1,726-nm lasers poised to revolutionize acne treatment, expert predicts
“Further study of both scarring and acne are needed to fully categorize the benefit and to optimize treatments,” Dr. Jeffrey Dover said.